Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Laura Pezzetti"'
Autor:
Matteo Brioschi, John Fischer, Roberto Cairoli, Stefano Rossetti, Laura Pezzetti, Michele Nichelatti, Mauro Turrini, Francesca Corlazzoli, Barbara Scarpati, Enrica Morra, Nicoletta Sacchi, Alessandro Beghini
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 12, Iss 11, Pp 866-876 (2010)
Core-binding factor leukemia (CBFL) is a subgroup of acutemyeloid leukemia (AML) characterized by genetic mutations involving the subunits of the core-binding factor (CBF). The leukemogenesis model for CBFL posits that one, or more, gene mutations in
Externí odkaz:
https://doaj.org/article/0593b60bb3cf453fa4a7f1e0086d1d43
Autor:
Rosa Greco, Silvio Veronese, Alessandro Beghini, Roberto Cairoli, Michele Nichelatti, Laura Pezzetti, Valentina Motta, Valentina Mancini, Marco Montillo, Livia Leuzzi, Giambattista Bertani
Publikováno v:
Blood. 138:2363-2363
Introduction Although CCAAT/enhancer binding protein alpha double mutated (CEBPADM) acute myeloid leukemia (AML) is considered a low-risk form of AML according to 2017 ELN recommendations, relapse remains a major cause of death. To assess the broader
Autor:
Elisabetta Volpato, Elisa Zucchetti, Roberto Cairoli, Mariateresa Pugliano, Tiziana Lamacchia, Laura Pezzetti, Giovanni Grillo, Liliana Intropido, Giambattista Bertani
Publikováno v:
Blood. 134:5633-5633
BACKGROUND Plerixafor (PLX) blocks the binding of stromal cell-derived factor to CXCR4, resulting in hematopoietic stem cell (HSC) release from the bone marrow. It has been successfully used as a mobilizing agent in poor mobilizers (PM). The best str
Autor:
Cristina Tresoldi, Mariella Cuzzola, Orietta Spinelli, Mario Cazzola, Andrea Bacigalupo, Silvia Luchetti, Ettore Rizzo, Silvia Zibellini, Laura Pezzetti, Silvia Catricalà, Benedetto Bruno, Marianna Rossi, Marta Ubezio, Simona Sica, Chiara Milanesi, Maria Teresa Voso, Emilio Paolo Alessandrino, Riccardo Bellazzi, Anna Gallì, Sarah Pozzi, Armando Santoro, Virginia Valeria Ferretti, Massimo Bernardi, Emanuele Angelucci, Alessandro Rambaldi, Alberto Bosi, Pietro Pioltelli, Paola Marenco, Ivan Limongelli, Fabio Ciceri, Matteo G. Della Porta, Alberto Malovini, Elli Papaemmanuil, Maria Teresa Van Lint, Francesca Bonifazi, Bernardino Allione, Alberto Riva
Purpose The genetic basis of myelodysplastic syndromes (MDS) is heterogeneous, and various combinations of somatic mutations are associated with different clinical phenotypes and outcomes. Whether the genetic basis of MDS influences the outcome of al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103a559448b6bc8ed4fe93871ba92a87
http://hdl.handle.net/10807/93944
http://hdl.handle.net/10807/93944
Autor:
Alessandro Beghini, Nicoletta Sacchi, Enrica Morra, Michele Nichelatti, Laura Pezzetti, Barbara Scarpati, Francesca Corlazzoli, Roberto Cairoli, Stefano Rossetti, John Fischer, Mauro Turrini, Matteo Brioschi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 12, Iss 11, Pp 866-876 (2010)
Core-binding factor leukemia (CBFL) is a subgroup of acutemyeloid leukemia (AML) characterized by genetic mutations involving the subunits of the core-binding factor (CBF). The leukemogenesis model for CBFL posits that one, or more, gene mutations in
Autor:
Marta Gatti, Fausto Baldanti, Giuliana Muti, Valentina Mancini, Catherine Klersy, Simonetta Granata, Enrica Morra, Giuseppe Gerna, Marianna Caramella, Livio Gargantini, Pierluigi Oreste, Laura Pezzetti
Publikováno v:
British Journal of Haematology. 122:927-933
Post-transplant lymphoproliferative disorders (PTLDs) are heterogeneous severe complications occurring in 1-10% of transplanted patients. In most cases, PTLDs are associated with Epstein-Barr virus (EBV) infection but, recently, some clinical studies
Autor:
Felicetto Ferrara, Alessandro Beghini, Liliana Inropido, Enrica Morra, Laura Pezzetti, Alessandro Marocchi, Simonetta Granata, Gianpaolo Nadali, Carla B. Ripamonti, Erika Ravelli, Assunta Viola, Chiara Cattaneo, Roberto Cairoli, Anna Maria Nosari, Giovanni Pizzolo, Michele Nichelatti, Giuseppe Rossi, Giambattista Bertani, Giovanni Grillo, Matteo Brioschi
Human tryptase is a serine protease expressed in mast-cells. We previously observed that AML blast cells, cultured in vitro from a KIT D816Y patient, give rise to adherent cells with mast-cell like phenotype and tryptase was released in the serum-fre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d3b3e3a7f07d83389bbdd5954d5da7
https://hdl.handle.net/10281/404338
https://hdl.handle.net/10281/404338
Autor:
Felicetto Ferrara, Alessandro Beghini, Giovanni Grillo, Giovanni Pizzolo, Liliana Intropido, Giuseppe Rossi, Carla B. Ripamonti, Laura Pezzetti, Gianbattista Bertani, Assunta Viola, Erika Ravelli, Enrica Morra, Gianpaolo Nadali, Chiara Cattaneo, Silvio Veronese, Annamaria Nosari, Michele Nichelatti, Alessandro Marocchi, Simonetta Granata, Patrizia Colapietro, Roberto Cairoli
α and β-tryptase genes cluster on the short arm of human chromosome 16 and encode lineage-associated serine proteases that are abundantly expressed in mast-cells and, in trace amounts, in basophils. Under physiologic conditions no other myeloid cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12aabf3a69e1e22d49cb9b993c4dbea9
https://hdl.handle.net/10281/411495
https://hdl.handle.net/10281/411495
Autor:
Felicetto Ferrara, Gianpaolo Nadali, Lidia Larizza, Antonio Cuneo, Assunta Viola, Carla B. Ripamonti, Monia Lunghi, Francesca Elice, Laura Pezzetti, Mario Lazzarino, Giovanni Pizzolo, Roberto Cairoli, Michele Nichelatti, Patrizia Colapietro, Alessandro Beghini, Giovanni Grillo, Francesco Rodeghiero, Enrica Morra
Distinct forms of tyrosine kinase domain (TKD), juxtamembrane domain, exon 8, and internal tandem duplication (ITD) mutations of c-KIT, were observed in about 46% of core binding factor leukemia (CBFL) patients. To evaluate their prognostic significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e529d34347d55ca0ac7bf3b5dbd1ad4
https://hdl.handle.net/10281/404337
https://hdl.handle.net/10281/404337
Autor:
Erica Ravelli, Livio Gargantini, Denis Ciapanna, Francesca Ricci, Claudia Baratè, Roberto Cairoli, Enrica Morra, Roberto Ripamonti, Laura Pezzetti, Valentina Mancini, Annamaria Nosari, Liliana Intropido
Background. Pegfilgrastim is a polyethylene glycol (PEG)-conjugated form of G-CSF in which filgrastim is bound covalently to a 20kDa PEG molecule; this formulation increases serum half-life of G-CSF due to decreased renal elimination. Following the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d80959755df7ebfcfbd21a94fc1749
https://hdl.handle.net/10281/411455
https://hdl.handle.net/10281/411455